Login

Friále invest in start-ups all over the world|Bryan Frist,Managing Partner,Friale 00:10:00

Share On Facebook Share On Twitter

Bryan Frist is the Founder & Managing Partner of Friále.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Reflecting on Ardian's Milestones and Commitment in 2021 | Dominique Senequier, President, Ardian.
00:10:00
Bridging Academia and Industry: Dr. V. Lakshmanan's Journey in Sustainable Innovation
00:10:00
Invests in entrepreneurs that focus on consumer|Mike Duboe,General Partner,Greylock
00:00:00
Rick Van Kirk, CEO of Pro-Dex, Inc
00:10:00
"Artur Popko, President of the Management Board at Budimex SA, presents company results to investors on inwestorzy.tv."|Artur Popko, President of the Management Board at Budimex SA
00:10:00
Ian Jamison on Exit Strategies and Changes in the PE Environment
00:10:00
Arcosa Advocating for Real Change | Antonio Carrillo, CEO, Arcosa IncACA:NYQ
00:10:00
The Articulate Leader Behind Avista Capital Partners and Advocate for Community Engagement|Thompson Dean,Co-Founder and Co-CEO - Avista Capital
00:00:00
Enrolling patients in its coronavirus-induced lung damage treatment study - David Mazzo, CEO, Caladrius Biosciences Inc
00:10:00
Aalberts: Pioneering Material Innovation for Tomorrow's World
00:10:00
Smart Money: Funding and Exit Trends in Today's Market|Anna Fang,investor,ZhenFund
00:10:00
Rodrigo Larraín, CEO of Cencosud, invites you to EtMday Santiago 2023!|CEO,Cencosud Shopping SA

© 2017 - Neuhu+